Other conditions Board decisions

The Veteran's claim for compensation under 38 U.S.C. § 1151 for residuals of clavicle surgery with left upper extremity (LUE) neurological damage is denied because the evidence does not show that VA was at fault in providing care, treatment, or examination.

The Veteran's initial disability rating for other specified trauma and stressor-related disorder was granted at a 70 percent level, effective from the date of claim. The appeal is not about service connection but rather about assigning an appropriate disability rating.

The Veteran's residuals of a radical prostatectomy are rated at 60 percent since June 12, 2023.,SMC based on loss of use of a creative organ is granted.

The Board has found that additional development is needed for the right thigh muscle injury claim due to inconsistencies in previous VA examinations. The Veteran's TDIU prior to May 17,2019 issue is also remanded as it could be significantly impacted by the severity of his service-connected right thigh injury.

The Veteran's angioedema with urticaria is granted a 30 percent rating from December 1, 2009. The issues of service connection for erectile dysfunction, knee conditions, low back condition, and TDIU are remanded.

The Board has vacated the decision denying an effective date prior to May 20, 2011, for SMC based on a left forefoot amputation. The appeal of the July 27, 2007, effective date is dismissed.

The Veteran's appeal for a higher rating for his TMJ condition was denied as the evidence did not show that his symptoms more nearly approximated those required for a 30 percent or 40 percent rating.,The Veteran's appeal for a compensable rating for his right little finger disability was also denied, with the Board finding no compensable rating available under Diagnostic Code 5230.

The Board denied an initial disability rating in excess of 10 percent for a left foot disorder, finding that the Veteran's symptoms are no more than moderate.

The Board has decided to remand the Veteran's claims for increased ratings for bilateral hip disabilities due to the need for updated VA treatment records and a new VA examination.

The Board has granted service connection for cancer of the larynx, finding that the Veteran was exposed to herbicide agents during his active service and that this exposure caused his condition.

The Board has granted a 30 percent rating for the Veteran's jaw condition as of September 10, 2017. Prior to this date, the Veteran was rated at 10 percent.

The Veteran's request for a waiver of recovery of overpayment of VA pension benefits was timely filed, and the appeal is remanded to correct pre-decisional duty-to-assist error.

The Veteran's left thumb basilar joint arthritis is rated at 20 percent, but no higher. The appeal for a greater rating is denied.,The Veteran's right thumb basilar joint arthritis is rated at 20 percent. The appeal for a greater rating is denied.

The Board has granted service connection for back, neck, and bilateral foot disabilities due to in-service injuries sustained during an assault. The decision resolves doubt in favor of the Veteran.

The Veteran's claim for service connection for groin/inguinal pain is being remanded due to a scheduling error in the VA examination process.

The Board dismissed the appeal because it lacks jurisdiction to review the claim for payment of non-VA medical services provided on April 9, 2020.

The Board denied the Veteran's claim for service connection for a back disability, finding no current disability and insufficient evidence to establish a link between his in-service symptoms and any present condition.

The Board has found that there is new and relevant evidence received, but a VA examination is needed to determine the nature and etiology of the Veteran's neck condition.

The appeal was dismissed due to the appellant's death, and no service connection issues were decided.

The Board dismissed the appeal because the claims for reimbursement of medical services provided from September 1, 2019, to September 8, 2019, were administratively approved by VA in January 2021.